CIK: 1242116 - Address: C/O Forte Biosciences, Inc., 3060 Pegasus Park Dr., Building 6, Dallas, TX 75247
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/14/23 17:34
1/4/23
CMRAComera Life Sciences Holdings, Inc.DEHealthDrugPharmaceutical PreparationsFinck Barbara KMADP.ad81.23074223D
9/12/18 16:05
9/10/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeM.d21.4202537D
9/12/18 16:05
9/10/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeS.d-3318.580-2-537D
8/15/18 16:05
8/13/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeM.d21.4202537D
8/15/18 16:05
8/13/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeS.d-3319.020-2-537D
7/11/18 16:05
7/9/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeM.dm21.4202537D
7/11/18 16:05
7/9/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeS.dm-2615.010-2-537D
6/20/18 16:09
6/18/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeM.d21.4202537D
6/20/18 16:09
6/18/18
CHRSCoherus Biosciences, Inc.DEHealthBioPrdBiological Products, (No DiagFinck Barbara KCAOChief MeS.d-2615.000-2-537D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact